Oregon Enacts Drug Price Transparency Law

Law360 (March 13, 2018, 6:44 PM EDT) -- Oregon’s governor on Tuesday signed legislation requiring drugmakers and health insurers to report extensive information about relatively pricey prescription drugs.

Democratic Gov. Kate Brown signed the legislation, H.B. 4005, after it easily cleared both chambers of the state Legislature in recent weeks. In addition to mandating new disclosures by drugmakers and insurers, the law creates a task force that will develop a strategy for greater transparency across the “entire supply chain of pharmaceutical products.”

In a statement on Tuesday, Brown said the new law “brings greater transparency around drug pricing, an important step towards making life-saving and essential drugs more available...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!